Royal Bank Of Canada Deciphera Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$13.58 - $17.36 $58,448 - $74,717	4,304 New	4,304 $67,000
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $218,841 - $279,756	-16,115 Reduced 78.92%	4,304 $67,000
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $88,179 - $144,261	8,722 Added 74.57%	20,419 $329,000
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $44,880 - $55,758	3,602 Added 44.5%	11,697 $148,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $24,222 - $29,111	1,824 Added 29.09%	8,095 $113,000
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $38,887 - $60,266	-2,727 Reduced 30.31%	6,271 $96,000
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $125,230 - $160,564	8,433 Added 1492.57%	8,998 $147,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $3,862 - $6,311	312 Added 123.32%	565 $10,000
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $19,950 - $30,616	-2,190 Reduced 89.64%	253 $3,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $41,769 - $67,548	-6,080 Reduced 71.34%	2,443 $23,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $61,630 - $297,188	8,004 Added 1542.2%	8,523 $83,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $12,542 - $17,609	474 Added 1053.33%	519 $18,000
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $1,472 - $2,157	45 New	45 $2,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.